The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.<\/p>\n
0747 ET \u2013 Novo Nordisk\u2019s shares seem to be overreacting to the news that the key ingredient in its Ozempic and Wegovy blockbuster drugs failed to show a benefit in Alzheimer\u2019s disease in clinical trials, analysts at J.P. Morgan say in a research note. While this means a potential positive surprise didn\u2019t materialize, it has no impact on forecasts for the Danish drugmaker, the analysts say. \u201cWe and the majority of the market had seen this trial as high risk and as a result we had included zero contribution from Alzheimer\u2019s disease in our forecasts,\u201d the analysts say. Consensus expectations include a minor contribution of 7 billion Danish kroner ($1.08 billion) in 2032 sales, or about 2% of the group\u2019s total, according to JPM. Shares fall 10%, dropping to levels last seen in 2021. (adria.calatayud@wsj.com)<\/p>\n
Copyright \u00a92025 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8<\/p>\n","protected":false},"excerpt":{"rendered":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET,…\n","protected":false},"author":2,"featured_media":152332,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[138,101456,89161,60453,89159,44547,47880,170,2285,101459,89160,3717,134,527,101458,101297,47884,6422,101462,101457,101463,30202,111,139,64,69,18154,47881,3383,101461,1518,101460,101455,1321,19201,1430,101230],"class_list":{"0":"post-152331","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-business","9":"tag-business-consumer-services","10":"tag-ce-industry-news-filter","11":"tag-consumer-services","12":"tag-content-types","13":"tag-corporate","14":"tag-corporate-industrial-news","15":"tag-development","16":"tag-diagnostic","17":"tag-diagnostic-medical-research-services","18":"tag-factiva-filters","19":"tag-general-news","20":"tag-health","21":"tag-healthcare","22":"tag-healthcare-support-services","23":"tag-healthcare-life-sciences","24":"tag-industrial-news","25":"tag-life-sciences","26":"tag-linkendrnrealtime-linkedarticle-dnco20251124007672","27":"tag-medical-research-services","28":"tag-new-products","29":"tag-new-products-services","30":"tag-new-zealand","31":"tag-newzealand","32":"tag-north-america","33":"tag-nz","34":"tag-political","35":"tag-political-general-news","36":"tag-products","37":"tag-products-services","38":"tag-research","39":"tag-research-development","40":"tag-scientific-research-services","41":"tag-services","42":"tag-synd","43":"tag-united-states","44":"tag-wsj-pro-wsj-com"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/152331","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/comments?post=152331"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/152331\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media\/152332"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media?parent=152331"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/categories?post=152331"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/tags?post=152331"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}